All News

The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.

2023 was an impactful year for the field of oncology pharmacy.

In 2024, Pharmacy Practice in Focus: Health Systems welcomes the launch of the peer-review process, with this issue containing our first peer-reviewed paper.

Biosimilars are proven to be highly similar to the original products with no clinical meaningful differences.

In addition to the current principles and treatment regimens, there are upcoming data on myelofibrosis drugs that could be reported as early as 2024.

Not only were individuals with BMIs of 30 and higher likely to have MGUS, but those who reported heavy smoking and short sleep were also more likely to have detectable levels of MGUS.

Biermaas said her team is continuing to focus on product availability globally, as well as the massive growth in GLP-1 diabetes and weight loss treatments.

Language barriers between pharmacists and patients impacts medication adherence, patient education, and overall health outcomes, resulting in patient harm.

BrainSee creates a new standard for progression prediction in Alzheimer disease, marking a step forward in brain health management with non-invasive screening.

The separation between those who travel for care compared to those who go to the local hospital may drive inequalities in health care.

RSV could interact with nerve cells, causing nerve damage and possible entry to the spinal cord.

The results also indicated that stress and blood sugar levels were higher among women who had a college degree and women with a higher income.

With the increase in counterfeit GLP-1 and GLP/GIP medications available online, education may be needed for patients around the dangers of unregulated medications.

According to the study investigators, findings indicat that pneumococcal vaccination in older adults and other interventions should be considered for reducing the disease burden.

The findings show a greater association with less ideal cardiovascular health scores for those who experienced their first infertility before age 35.

According to the authors, the findings may have broad implications for understanding recombination and viral evolution within various organisms.

We owe it to our seniors to listen to their needs and ensure pharmacists have the support they need to continue to play a vital role in our communities as frontline providers of essential health care.

At a young age, hands-on learning about nutrition can promote long-term appreciation of fresh food and food experiences.

These patients may have a similar genetic susceptibility for type 2 diabetes, although they have an individual risk for GDM independent of the risk of type 2 diabetes.

To have skin-deep resilience is to overcome adversity to achieve success, be it psychological or academic.

A majority of patients who received first-line chemotherapy switched to amivantamab-vmjw plus chemotherapy as second-line therapy.

A leukemia clinical pharmacy specialist delves into the significance of educating patients on treatments and serving as a resource for both patients and health care providers.

In addition, patients who were treated with liso-cel therapy had a higher average life expectancy and QALYs, compared to those who were treated with standard care.

High intensity interval training (HIIT) showed improved heart failure outcomes compared to medium chain triacylglycerol, used for endurance performance among athletes, and the usual care.

The update includes a recommended triple therapy with belimumab as a first line treatment for class III or IV lupus nephritis following the approvals of belimumab and voclosporin.

The data also suggest that further studies investigating a plausible causal relationship between pneumonia and type 1 diabetes are needed.

Variations and conditions included in existing state bills, however, limit the effectiveness of this approach.